{
    "code": 0,
    "data": [
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a6b33b7-0ad9-4cb5-aa35-ce40f863a6ee.pdf",
            "news_date": "2026-02-10 17:11:47"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of the Listing Regulations please find enclosed Press Release on the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e2af189-46fb-46ad-8ce4-64a5c77357da.pdf",
            "news_date": "2026-02-10 15:03:39"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015; and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February 2026 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 10th February2026 inter-alia has approve the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2025;",
            "news_id": "fe3df97c-79a8-4beb-ba47-9d584a408d1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df5a90e4-ae67-435e-ab91-11731ab9fef9.pdf",
            "news_date": "2026-02-10 14:44:40",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015; and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February 2026 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 10th February2026 inter-alia has approve the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2025;",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df5a90e4-ae67-435e-ab91-11731ab9fef9.pdf",
            "news_date": "2026-02-10 14:44:40"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February 2026 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e.10th February 2026 inter-alia has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57462a53-02fd-41ce-9109-bb33329af5cd.pdf",
            "news_date": "2026-02-10 14:32:34"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited (The Company)",
            "news_body": "Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 10th February 2026 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ae1c01-42d7-41dc-ac26-7513f064b8ae.pdf",
            "news_date": "2026-02-04 14:44:08"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that Dr. Sanjeev Kumar Sharma President- Manufacturing Quality & R&D designated as Senior Management Personnel (SMP) of the Company has tendered his resignation from the services of the Company effective from close of business hours of 2nd February 2026 due to personal reasons and consequently shall cease to be SMP of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b65fabd-603b-4c9f-9fb6-4657182ac1ab.pdf",
            "news_date": "2026-02-03 16:10:40"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 0f Listing Regulations please find enclosed Press Release- \"Wockhardts Fifth Novel Antibiotic Foviscu (WCK 4282) Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.\":",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=620b84e7-1699-42c3-9398-8ed8a663b5be.pdf",
            "news_date": "2026-01-27 09:00:48"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings.",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 we wish to inform you that CFC Finlease Private Limited a SEBI - Licensed ESG rating provider has voluntarily assigned an ESG rating of 70 for the year 2025 as part of its ESG assessement process.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82935217-0a45-410d-9ff3-01098fd885e0.pdf",
            "news_date": "2026-01-16 16:36:45"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed the Certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company for the quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=595513cf-7565-42a1-adf0-e86bef552a80.pdf",
            "news_date": "2026-01-08 14:46:29"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- \"Wockhardt Files Marketing Authorisation Application for WCK 5222 with European Medicines Agency\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5f45527-2fa1-4a53-a141-4e1aeeac4aa3.pdf",
            "news_date": "2026-01-07 09:06:24"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby inform you that ESG Risk Assessments & Insights Limited a SEBI registered ESG Rating provider has voluntarily assigned as ESG Rating of 73 (Excellent) for the year 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2f25b5f-0f71-48d9-8e26-da9f986dd692.pdf",
            "news_date": "2026-01-01 17:39:45"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby inform you that SES ESG Research Pvt ltd has voluntarily assigned an ESG rating of 67.3 for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8672a299-738c-46f7-940e-d8649f823687.pdf",
            "news_date": "2025-12-31 18:06:52"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "In terms of provision of Regulation 30 (read with Part A of Schedule lll) and other applicable provisions of the SEBI (LODR)Regulations 2015 we wish to inform you that the Company is in receipt of the Tax Demand Order dated 26th December 2025 passed by the Superintendent Central GST Range- 11 Division-lll  Ghaziabad for the period FY 2019-20 amounting to Rs. 9023518/- inclusive of Penalty of Rs. 2807984/-.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bb6d48f-4fec-4fac-abac-b67396bf3436.pdf",
            "news_date": "2025-12-31 16:31:42"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations please find enclosed Press Release - \"European Medicines Agency Grants Accelerated Assessment to WCK 5222\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4aa07c1-c7a5-47d1-b300-bb9871debb1b.pdf",
            "news_date": "2025-12-31 12:26:33"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that pursuant to Companys Code of Conduct for regulating monitoring and reporting trading by designated persons the Trading Window for dealing in equity shares of the Company will be closed from 1st January 2026 until 48 (Forty-eight) hours after the declaration of Unaudited Financial Results of the Company for the quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c648223-c278-45a3-86d2-60c6e6596b58.pdf",
            "news_date": "2025-12-29 11:16:44"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Incorporation Of Step-Down Subsidiaries Of The Company.\r\n\r\n",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that Wockhardt Bio AG a Subsidiary of the Company has incorporated three new Wholly Owned Subsidiaries Wockhardt Swiss AG (Switzerland) Wockhardt Suisse USA Holding Corporation (USA) and Wockhardt Suisse USA LLC (USA). Consequent to the Incorporation Wockhardt Swiss AG Wockhardt Suisse USA Holding Corporation and Wockhardt Suisse USA LLC have become Step- Down Subsidiaries of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2fceb99-61b8-4684-b4f1-d9eeba8f87d0.pdf",
            "news_date": "2025-12-16 16:42:32"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Voting Results of Postal Ballot along with Scrutinizers Report dated 15th December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d1a46cd-50d2-4757-8daf-5fb6d8831b93.pdf",
            "news_date": "2025-12-15 18:07:06"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Voting Results of the Postal Ballot along with Scrutinizers Report dated 15th December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14f75ce0-8c90-49b0-a50a-c3fc11c040f4.pdf",
            "news_date": "2025-12-15 18:00:03"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reply To Email Related To Volume Movement",
            "news_body": "In response to your captioned letter dated 02.12.2025 we would like to state that we have reviewed and verified the relevant internal records operations and developments and hereby confirm that there is no information/announcement or events which in our opinion has a bearing on price/volume movement which require disclosure under Reg. 30 of SEBI Listing Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45b4b2e7-88d3-4737-bf23-88a61c78b42c.pdf",
            "news_date": "2025-12-02 13:15:56"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Wockhardt Ltd",
            "news_body": "The Exchange has sought clarification from Wockhardt Ltd on December 2 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-12-02 11:57:28"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of Listing Regulations please find \r\nenclosed Press Release- \"US FDA Accepts Wockhardts New Drug Application for Breakthrough Antibiotic Zaynich\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=929bc7d9-e65e-4767-9ffc-65919d9a0362.pdf",
            "news_date": "2025-12-01 11:38:59"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI(LODR) Regulations 2015 we enclose herewith copy of the third newspaper advertisement published today i.e. 28th November 2025 pursuant to SEBI Circular no SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2 2025 regarding the opening of special window for re-lodgement of the transfer requests of shares held in physical form.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d100d79b-bc86-4c1f-bc98-f40bdb5568ad.pdf",
            "news_date": "2025-11-28 12:52:02"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith copies of newspaper advertisement with respect to Postal Ballot Notice published by the Company on 15th November 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e62cff0c-a273-4fa7-b298-a5cba4b4906e.pdf",
            "news_date": "2025-11-15 17:48:02"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations we are enclosing herewith notice of Postal Ballot dated 3rd November 2025 along with Explanatory Statement for seeking Members approval by way of special resolution for appointment of Mr. Om Prakash Bhatt (DIN: 00548091) as a Non-Executive Independent Director of the Company for a term of 5 years from 3rd November 2025 to 2nd November 2030 and continuation of his directorship notwithstanding his attaining the age of 75 years during the term.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f282f575-98d2-4720-aed4-eebb49ff6254.pdf",
            "news_date": "2025-11-14 18:39:11"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reply To Your Email Dated 4Th November 2025 Relating To Volume Movement",
            "news_body": "This is with reference to your letter dated 4th November 2025. Kindly find our response to the same attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dacb3d5-2b3e-4241-98f0-497e53e4b3ed.pdf",
            "news_date": "2025-11-04 13:09:15"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Wockhardt Ltd",
            "news_body": "The Exchange has sought clarification from Wockhardt Ltd on November 04 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-11-04 11:18:23"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Pursuant to Regulation 32(6) of the SEBI(LODR)  Regulations 2015 read with Regulation 173A of SEBI (ICDR Regulations) 2018 enlcosed herewith Monitoring Agency Report for the quarter ended 30th September 2025 received from Crisil as reviewed and taken record by Audit Committee and Board of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2483b3d8-7868-46d5-87df-9def4213fb60.pdf",
            "news_date": "2025-11-03 18:17:12"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of the Listing Regulations please find enclosed Press Release on the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef6b0c4c-4451-4c17-a087-2060b876f451.pdf",
            "news_date": "2025-11-03 15:31:34"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 3rd November 2025 has approved the appointment of Mr. Om Prakash Bhatt (DIN: 00548091) as an Additional Director (Non -Executive Independent )Director of the Company with immediate effect.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e17f14d-e970-47d7-bfac-f4d1ea5fb355.pdf",
            "news_date": "2025-11-03 15:20:20"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI *LODR) Regulation 2015 please find attached herewith un-audited financial results (standalone and consolited) for the quarter and half year ended 30th September 2025.",
            "news_id": "eab4658d-9320-4c6e-b556-08b6575d7812",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9b0108-a562-499f-92cb-978f4f7e64b9.pdf",
            "news_date": "2025-11-03 15:08:40",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI *LODR) Regulation 2015 please find attached herewith un-audited financial results (standalone and consolited) for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9b0108-a562-499f-92cb-978f4f7e64b9.pdf",
            "news_date": "2025-11-03 15:08:40"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 (Listing Regulations) and in continuation to our letter bearing Ref No. WOCK/SEC/SE/2025-26/044 dated 29th October 2025 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 3rd November 2025 inter-alia has approved unaudited financial results(Standalone and Consolidated) for the quarter and half year ended 30th September 2025. and appointment of Mr. Om Prakash Bhatt as an Additional ( Non Executive-Independent) Director of the Company with immediate effect.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a32de42-dc6d-4be6-a0a6-7bbda53d1b72.pdf",
            "news_date": "2025-11-03 14:49:19"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ( The Company).",
            "news_body": "Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday 3rd November 2025 inter- alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e46ebcf-0c02-4129-adc6-995171e5b39f.pdf",
            "news_date": "2025-10-29 10:33:11"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed the Certificate received from MUFG Intime India Private Limited RTA of the Company for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79d958ea-a7b3-499a-a22e-b37c6964f0a0.pdf",
            "news_date": "2025-10-13 16:53:06"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of Listing Regulations  please find enclosed Press Release- \"Wockhardt submits new drug  Application to U.S. FDA for Zidebactam-Cefepime (WCK 5222) for Treatment of serious Gram-Negative Infections\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9438fee-d972-4c78-85a1-168501cc4f5c.pdf",
            "news_date": "2025-10-01 09:00:41"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith copy of the second newspaper advertisement published today i.e. 29th September 2025 pursuant to SEBI Circular no. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2 2025 regarding the opening of special window for re-lodgement of the transfer requests of shares held in physical form.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7998963-decb-4351-b5b8-7b83723fa014.pdf",
            "news_date": "2025-09-29 15:31:34"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of Listing Regulation please find enclosed Press Release - \"Prestigious Medical and Public Health Journal \" The Lancet Regional Health\" Publishes Pivotal Phase 3 Clinical Study on Miqnaf (Nafithromycin)- A Landmark for Indias Antibiotic Innovation\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a3e5b6e-a36d-40be-8d4f-6258c35b0fba.pdf",
            "news_date": "2025-09-25 16:14:53"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Pursuant to Companys Code of Conduct for regulating monitoring and reporting trading by designated persons the Trading Window for dealing in equity shares of the Company will be closed from 1st October 2025 until 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bfde8bf-b2e0-4d2e-83d1-720d5ba747ce.pdf",
            "news_date": "2025-09-25 14:48:42"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations read with Master Circular dated November 11 2024 we wish to inform you that ESG Risk Assessment and Insights Limited a SEBI registered ESG rating provider has voluntarily assigned an ESG rating of 68 (Strong) for the Financial Year 2024-25 as a part of its annual ESG assessment process based on Companys public disclosures and other publicly available information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d6b3044-e090-4d5e-b3b8-81f485390d46.pdf",
            "news_date": "2025-09-12 18:12:52"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "This is to inform you that ICRA Limited (ICRA) has upgraded the credit ratings and revised the outlook from stable to positive.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35f4661c-4390-4e75-a258-a8910c1c0f79.pdf",
            "news_date": "2025-08-26 16:29:53"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We wish to inform you that the Share Allotment Committee of the Board of Directors of the Company has allotted 6600 equity shares of face value of Rs/- 5 each on 21st August 2025 pursuant to exercise of stock options under Employee Stock Option Scheme - 2011 of the Company.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe129980-10b9-43b5-84b3-922949501dbc.pdf",
            "news_date": "2025-08-21 12:47:33"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find enclose herewith the Scrutinizers Report on the voting results of remote e- voting and e- voting during the 26th Annual General Meeting of the Company held today i.e. 8th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a479d95-e371-491f-89d7-bca9fdb92e17.pdf",
            "news_date": "2025-08-08 20:33:24"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Pursuant to Regulation 30 read with Para A of Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements ) Regulation  2015 we enclose herewith the proceedings of the 26th AGM of the Company held today i.e on Friday 8th August 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26cb7d20-7798-48b4-8d6f-70f8ff70054d.pdf",
            "news_date": "2025-08-08 20:13:47"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Pursuant to Regulation 32(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 read with Regulation 173A of the SEBI ( Issue of Capital and Disclosure Requirements) Regulations 2018 please find enclosed Monitoring Agency Report for the quarter ended 30th June 2025 issued by CRISIL Ratings Limited towards utilization of proceeds of the Companys  Qualified Institutions Placement of approx. ? 1000 Crore vide Placement Document dated 11th November 2024 duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5092145e-2415-4957-98bc-5d4d43165f0f.pdf",
            "news_date": "2025-08-08 19:10:33"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of the Listing Regulations please find enclosed Press Release on the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10b08eb6-88c8-4790-9d03-d4e55d3cc852.pdf",
            "news_date": "2025-08-08 14:57:41"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 We wish to inform you that the Board of Directors at its meeting held today i.e. 8th August 2025 has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2025.",
            "news_id": "0919e133-ae41-4224-a476-ffdf93f43557",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c10897-e8de-49ea-8ffc-ae919060aa5f.pdf",
            "news_date": "2025-08-08 14:10:17",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 We wish to inform you that the Board of Directors at its meeting held today i.e. 8th August 2025 has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c10897-e8de-49ea-8ffc-ae919060aa5f.pdf",
            "news_date": "2025-08-08 14:10:17"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 (Listing Regulations) and in continuation to our letter bearing reference no.: WOCK/SEC/SE/2025-26/026 dated 1st August 2025 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 8th August 2025 inter-alia has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=217e77ba-7200-4fdf-94c5-c02edf89d674.pdf",
            "news_date": "2025-08-08 13:56:57"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited (\"The Company\").",
            "news_body": "Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 8th August 2025 inter- alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fd6023f-96d0-49e4-9eea-55077920b3cd.pdf",
            "news_date": "2025-08-01 16:14:45"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 read with Schedule III part A para A of the SEBI (LODR) Regulations 2015 we enclose herewith copy of the newspaper advertisement published today i.e. 31st July 2025 pursuant to SEBI Circular no. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2 2025 regarding the opening of special window for re-lodgement of the transfer request of shares held in physical form.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3979fc14-736d-4de2-895e-d8545147afb7.pdf",
            "news_date": "2025-07-31 15:05:03"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- \" Leading U.K Medical Journal publishes a Complex Case of severe Pan- drug Resistant Infection in US Liver Transplant Patient Successfully Treated with Zaynich/ (Zidebactam/Cefepime WCK 5222)\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c5006f3-2b69-46cc-a7bd-39f5f74ef769.pdf",
            "news_date": "2025-07-28 08:59:50"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please  find enclosed herewith newspaper extract of public notice issued by the Company pertaining to the 26th Annual General Meeting of company convened to be held on Friday 8th August 2025 at 3:30 p.m. (IST) through Video Conferencing (VC) / Other Audio Video Means (OAVM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55a344e0-0e19-4ec2-a720-c891929f39da.pdf",
            "news_date": "2025-07-18 15:58:09"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed the Compliance Certificate received from MUFG Intime India Private Limited RTA of the Company for the Quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77122cf6-c9f0-468f-8939-521a708ec4fa.pdf",
            "news_date": "2025-07-17 15:14:09"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed herewith the BRSR of the Company for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=058cfc7b-5273-47df-80f4-ec9b9ef64077.pdf",
            "news_date": "2025-07-16 22:09:02"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For The Purpose Of 25Th Annual General Meeting (AGM) Of The Company.",
            "news_body": "Pursuant to Regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we wish to inform you that the record date for the purpose of 26th AGM of the Members of Wockhardt Limited is Scheduled to be held on Friday 8th August 2025 at 3.30 p.m. (IST) through Video Conference (VC)/ Other Audio Visual Means (OVAM) shall be Friday 1st August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ce5d293-2288-44c3-b76d-ffe5aa78d787.pdf",
            "news_date": "2025-07-16 21:52:45"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 26Th Annual General Meeting(AGM) Of The Company For The Financial Year 2024-25",
            "news_body": "The 26th AGM of the Members of Wockhardt Limited will be held on Friday 8th August 2025 at 3.30 pm IST through Video Conference (VC)/ Other Audio Visual Means (OAVM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0fd30dd-29a6-40a5-8d26-106200fd43d6.pdf",
            "news_date": "2025-07-16 20:52:35"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "The 26th Annual General Meeting of the Members of Wockhardt Limited will be held on Friday 8th August 2025 at 3:30 pm (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).\r\n\r\nPursuant to Regulation 29 30 and 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we submit herewith the Notice convening the 26th Annual General Meeting and the Annual Report of the Company for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba0eb496-e71f-4495-aaaf-8e84cd742086.pdf",
            "news_date": "2025-07-16 20:43:01"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "The 26th Annual General Meeting of the Members of Wockhardt Limited will be held on Friday 8th August 2025 at 3:30 pm (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).\r\n\r\nPursuant to Regulation 29 30 and 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we submit herewith the Notice convening the 26th Annual General Meeting and the Annual Report of the Company for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae30b5ab-b461-46aa-ae0b-2ffd25da4f56.pdf",
            "news_date": "2025-07-16 20:42:07"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find enclosed Press Release \"Wockhardt Initiates Strategic Realignment of US Operations to Focus on Innovative Portfolio\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99ec78a3-cb63-41f8-be02-4fb9384ce278.pdf",
            "news_date": "2025-07-11 16:12:47"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that pursuant to Companys Code of Conduct for regulating monitoring and reporting trading by designated persons the Trading Window for dealing in equity shares of the Company will be closed from 1st July 2025 until 48 hours after the declaration of unaudited financial results of the company for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=174ef0ec-af4d-427c-a88b-82acce5bb42d.pdf",
            "news_date": "2025-06-26 13:14:48"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference number Ref no: WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed the transcript of the presentation made in the Investor meeting held on Thursday 5th June 2025 for your information and records.",
            "news_id": "b85133eb-7384-45eb-a15c-5d7aaea10cff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c50e942-c9ad-4a5a-840f-10e4b31f502c.pdf",
            "news_date": "2025-06-11 15:33:56",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference number Ref no: WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed the transcript of the presentation made in the Investor meeting held on Thursday 5th June 2025 for your information and records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c50e942-c9ad-4a5a-840f-10e4b31f502c.pdf",
            "news_date": "2025-06-11 15:33:56"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended and in  continuation of our letter bearing reference number WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed herewith a copy of the updated Investor Presentation.",
            "news_id": "2778e7f8-cda4-421d-88d9-d968219da983",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=163c4bb3-3eeb-4f48-857d-3931854e5e37.pdf",
            "news_date": "2025-06-05 15:11:14",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended and in  continuation of our letter bearing reference number WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed herewith a copy of the updated Investor Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=163c4bb3-3eeb-4f48-857d-3931854e5e37.pdf",
            "news_date": "2025-06-05 15:11:14"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 and in continuation to our letter dated 2nd June 2025 Please find enclosed herewith a copy of Investor Presentation to be made at the Investor Meet scheduled to be held today i.e. 5th June 2025.",
            "news_id": "90c50c98-7441-4f3e-b4a8-c47f5e25ce71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e0435e0-06b2-41bc-8a9a-70ec2534cf18.pdf",
            "news_date": "2025-06-05 09:06:55",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 and in continuation to our letter dated 2nd June 2025 Please find enclosed herewith a copy of Investor Presentation to be made at the Investor Meet scheduled to be held today i.e. 5th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e0435e0-06b2-41bc-8a9a-70ec2534cf18.pdf",
            "news_date": "2025-06-05 09:06:55"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company will hold an Investor meet/call on Thursday 5th June 2025 at 11:00 hrs IST through VC and in-person as detailed in the enclosed invite.\r\n \r\nThe meeting/call will be initiated with a presentation by Dr. Murtaza Khorakiwala Managing Director and will be followed by a Q&A Session in presence of Dr. Habil Khorakiwala Chairman.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84bf214c-5e51-4382-b8fa-ad48e1ba8dc8.pdf",
            "news_date": "2025-06-02 20:00:39"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 please find enclosed herewith Press Release on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1cb331c-4f4c-4178-9a80-c2eccea86e0c.pdf",
            "news_date": "2025-05-29 17:34:13"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulation 2015 Please find enclosed herewith disclosure in respect of 1) Re-appointment of Mr. Akhilesh Krishna Gupta Independent Director; and 2) Appointment of Mr. Virendra G. Bhatt as Secretarial Auditor of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f1d1b22-737a-4781-a154-5e34f580a923.pdf",
            "news_date": "2025-05-29 15:16:30"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated Financial Results.",
            "news_id": "0dd617dc-231b-4943-87dd-62adaf42a3d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a54ea2-502e-4b33-b9f1-cc1d8807cf98.pdf",
            "news_date": "2025-05-29 15:11:32",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a54ea2-502e-4b33-b9f1-cc1d8807cf98.pdf",
            "news_date": "2025-05-29 15:11:32"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2025.",
            "news_id": "e761b5a0-009c-4757-b060-afdb8c7a1622",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bd6f3ea-cd91-4926-a06c-63d617ab3dd7.pdf",
            "news_date": "2025-05-29 15:03:46",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bd6f3ea-cd91-4926-a06c-63d617ab3dd7.pdf",
            "news_date": "2025-05-29 15:03:46"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Pursuant To Regulation 29(1) (A) And (D) Of SEBI LODR Regulations We Wish To Inform You That A Meeting Of The Board Of Directors Of The Company Will Be Held On Thursday 29Th May 2025",
            "news_body": "Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve (1)The Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2025; & \r\n2) Raising of funds as mentioned in the attached intimation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39f7f665-2295-42ac-b869-c012e72337c9.pdf",
            "news_date": "2025-05-23 16:35:04"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; we enclose herewith the Annual Secretarial Compliance Report for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b4b621-6cb0-461f-867e-7ae175dbe8bd.pdf",
            "news_date": "2025-05-22 16:42:46"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Pursuant to Regulation 32(6) of SEBI ( Listing Obligations & Disclosure Requirements) Regulations 2015 read with regulation 173 A of the SEBI (Issue of Capital & Disclosure Requirements) Regulations 2018 please find enclosed Monitoring Agency Reports towards utilisations of proceeds of the Qualified Institutions Placement (\"QIPs\") for the quarter ended 31st March 2025 issued by CRISIL Ratings Limited duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=067f282e-fcbf-4951-bfa0-896ec9bfcf25.pdf",
            "news_date": "2025-05-14 18:44:18"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI ( Depositories and Participants ) Regulations  please find enclosed the Compliance Certificate received from MUFG Intime India Private Limited Registrar and Transfer Agent of the Company for the quarter ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab3aebb3-a75f-4753-bf43-7d9173f3e6ab.pdf",
            "news_date": "2025-04-11 16:52:14"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Intimation For Incorporation Of A Step-Down Subsidiary Company\r\n\r\n",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that Wockhardt Bio AG a subsidiary of the Company has incorporated a new Wholly Owned Subsidiary in Ireland by the name Wockhardt Antibiotics (Ireland) Limited. Consequent to the Incorporation Wockhardt Antibiotics (Ireland) Limited has become a Step- Down Subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2f71835-c179-49ae-b461-a167ce38704d.pdf",
            "news_date": "2025-04-08 17:12:10"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations please find enclosed Press Release - \"Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with ZaynichTM (Zidebactam/Cefepime WCK 5222)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17ab8abc-44d4-4025-b432-3f223c02edac.pdf",
            "news_date": "2025-04-01 09:03:12"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that pursuant to Companys Code of Conduct for regulating monitoring and reporting trading by designated persons (the Code) the Trading Window for dealing in equity shares of the Company will be closed from 1st April 2025 until 48 hours after the declaration of audited financial results of the Company for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2dd0114-1842-4aab-ae5c-beac3c937638.pdf",
            "news_date": "2025-03-27 12:39:04"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13250 equity shares of face value Rs. 5/- each on 14th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e283307-1d53-4c38-91c1-031e7b3920c6.pdf",
            "news_date": "2025-02-14 19:14:22"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13250 equity shares of face value Rs. 5/- each on 14th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74fa301f-fa0d-43cc-9310-a2becf43e25e.pdf",
            "news_date": "2025-02-14 19:13:20"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "We are submitting herewith the Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30829e78-b59f-408f-b106-16059cd230e5.pdf",
            "news_date": "2025-02-07 21:08:28"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placements For The Quarter Ended 31St December 2024",
            "news_body": "Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 we  hereby confirm that there has been no deviation in the utilisation of the issue proceeds from the object as stated in the Placement Documents dated 26th March 2024 and 11th November 2024 and accordingly the Statements of Deviations in the prescribed format confirming Nil deviation duly reviewed by the Audit Committee are attached",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e464e07-3311-409e-9de1-428ea1cde7b5.pdf",
            "news_date": "2025-02-07 20:10:46"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Regulation 173(A) of the SEBI ( Issue of Capital and Disclosure Requirements) Regulations 2018 please find attached Monitoring Agency Reports towards utilisation of proceeds of following Qualified institutions Placements (\"QIPs\") for the quarter ended 31st December 2024 issued by CRISIL Rating Limited duly reviewed and taken on record by Board of Directors & Audit Committee of the Company\r\n1. QIP of Rs. 480.04 crore vide Placement Document dated 26.03.2024 (Annexure 1)\r\n2. QIP of Approx. Rs. 1000 crore vide Placement Document dated 11.11.2024 (Annexure 2)\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0454af3-09de-4830-a632-ce8718a99b64.pdf",
            "news_date": "2025-02-07 19:50:33"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of the Listing Regulations please find enclosed Press Release on the Un-audited Financial Results(Standalone and Consolidated) for the quarter and nine months ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2ffa58a-68a0-4191-a436-71c4e59e4fc7.pdf",
            "news_date": "2025-02-07 16:14:44"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/086 dated 3rd February 2025 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 7th February 2025 inter-alia have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2024\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82cf75e3-84b9-4211-be83-9af5d1fae463.pdf",
            "news_date": "2025-02-07 13:43:50"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited\r\n",
            "news_body": "WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and is closure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 7th February 2025 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months  ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9ff4010-0389-4e12-906e-4193c9e7490e.pdf",
            "news_date": "2025-02-03 11:32:50"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations please find enclosed Press Release - \"Wockhardts Zaynich (Zidebactam/Cefepime WCK 5222) achieves highest-ever efficacy meeting superiority in a global pivotal registration-enabling Phase III study in complicated urinary infection (cUTI) achieving 96.8% clinical cure rate\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fcaf456-4455-4b0f-9a9d-5eaa5f672bcb.pdf",
            "news_date": "2025-01-31 08:58:56"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find attached the Compliance Certificate received from MUFG Intime India Pvt Ltd (Formerly known as Link Intime India Pvt Ltd) RTA of the Company for the Quarter ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da699652-de75-471e-89f0-c4308c1721c5.pdf",
            "news_date": "2025-01-14 10:32:30"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations please find attached Press Release titled \"Zaynich(Zidebactum/Cefepime. WCK 5222)achieves over 97% Efficacy in Clinical Study for serious infections caused by by Meropenem-Resistant Gram-Negative Pathogens.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=385c2690-6c1d-4268-8896-6030aa222440.pdf",
            "news_date": "2025-01-13 09:00:50"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of the Listing Regulations please find attached Press Release titled- Indian Drug Regulator Approves Wockhardts New Generation Oral Antibiotic MiqnafR (Nafithromycin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71916b98-d6cb-4628-b0f6-ff27fd0ef44d.pdf",
            "news_date": "2025-01-02 19:15:26"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations, please find attached Press Release titled, Zaynich TM (Zidebactam/Cefepime, WCK 5222) enables US cancer patient undergo successful liver transplant and resume chemotheraphy by eradicating dual extreme-drug resistant Gram negative pathogens",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=093f4083-6025-44e5-b1f5-c8336fd8bd5f.pdf",
            "news_date": "2024-12-16 08:58:25"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Pursuant to the requirement of the Regulation 39(3) of the SEBI Listing Regulations, we wish to inform you that our RTA has intimated about receipt of the request for the issuance of Duplicate Share Certificate in lieu of the Original Certificate lost/misplaced.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99110e24-b743-4e50-8101-9f8e9886cae0.pdf",
            "news_date": "2024-11-27 16:34:59"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Pursuant to the requirement of the Regulation 39(3) of the SEBI Listing Regulations, we wish to inform the Stock Exchange that our RTA has intimated about receipt of the Duplicate Share Certificates in lieu of the original Share Certificate reported lost/misplaced.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8406a0e-1b70-4c2c-9d0c-ebe23f38018d.pdf",
            "news_date": "2024-11-21 15:07:42"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Pursuant to the requirement of regulation 39(3) of the Listing Regulations, we wish tp inform you that Link Intime India Private Limited, our RTA has intimated regarding the loss of share certificate by the shareholder.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db050336-12a1-4a7e-8da2-f250c059d480.pdf",
            "news_date": "2024-11-18 12:07:42"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Pursuant to Regulation 39(3) of the Listing Regulations, we wish to inform you that our RTA has intimated regarding loss of share certificate by the Shareholder.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54345a0b-1a25-4024-8d20-56724a10d9a0.pdf",
            "news_date": "2024-11-14 15:35:38"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "Reg. 32 (1), (3) - Statement of Deviation & Variation",
            "caption": "Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placement For The Quarter Ended 30Th June, 2024 Confirming That There Has Been No Deviation In The Utilization Of Issue Proceeds.",
            "news_body": "Pursuant to Regulation 32(1) of SEBI LODR Regulations, 2015, please find enclosed the Statement of Deviation or Variation of fund raised through QIP for the Quarter ended 30th September, 2024 confirming there has been no deviation in the utilization of Issue proceeds from the objects as stated in the Placement Document dated 26th March, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ec369c-0194-4504-9a2f-d6eadb8ef162.pdf",
            "news_date": "2024-11-13 18:52:28"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Please Find Enclosed Herewith The Monitoring Agency Report Towards Utilization Of Proceeds Of Qualified Institutions Placement ('QIP') For The Quarter Ended September 30, 2024, Issued By CRISIL Ratings Limited.",
            "news_body": "Pursuant to Regulation 32(6) of SEBI LODR Regulation, 2015 read with Regulation 173A of SEBI ICDR Regulation, 2018 Please find enclosed herewith the The Monitoring Agency Report for the Quarter ended 30th September, 2024 issued by CRISIL Ratings Ltd.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ee77679-d3df-44de-b158-bd8c7939d4e3.pdf",
            "news_date": "2024-11-13 18:46:29"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Pursuant to Regulation  30 of SEBI LODR Regulations, 2015, Please find enclosed Press Release on the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=769fd194-ce46-4c16-9fbe-af6d7584653e.pdf",
            "news_date": "2024-11-13 17:51:03"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith Unaudited Financial Results for the quarter and half year ended September 30, 2024 along with Limited Review Reports thereon.",
            "news_id": "68584f13-bc6f-4a30-b32d-d66d75258860",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8d0fa0-04b7-44a3-8a31-e3b76de5b3b1.pdf",
            "news_date": "2024-11-13 13:35:48",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith Unaudited Financial Results for the quarter and half year ended September 30, 2024 along with Limited Review Reports thereon.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8d0fa0-04b7-44a3-8a31-e3b76de5b3b1.pdf",
            "news_date": "2024-11-13 13:35:48"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Please find enclosed herewith the Outcome of the Capital Raising Committee of Wockhardt Limited for allotment of 90,49,773 equity shares pursuant to Qualified Institutional Placement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=575b4dca-4628-4808-957c-08a7456dad47.pdf",
            "news_date": "2024-11-11 23:54:30"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee",
            "news_body": "Outcome of the meeting of the Capital Raising Committee for closure of Issue, approval of issue price, approval  of placement document and approval of confirmation of allocation note for Qualified institutions placement of equity shares of face value of ?5 each to Qualified Institutional Buyers by Wockhardt Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e82960a-b5f4-4e5e-a23f-ad3c8d43849c.pdf",
            "news_date": "2024-11-11 23:23:10"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited",
            "news_body": "WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 13th November, 2024, inter-alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the half year ended 30th September, 2024.In view of the above, the trading window for dealing in the shares of the Company, which was closed from Tuesday, 1st October, 2024, shall remain closed until 48 hours after the declaration of financial results on 13th November, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce22ded8-92c6-4ae6-a3a3-4e2ea6ac1b2b.pdf",
            "news_date": "2024-11-08 15:44:39"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee For Qualified Institutions Placement Of Equity Shares Of Face Value Of ? 5 Each (The 'Equity Shares') To Qualified Institutional Buyers ('QIB').",
            "news_body": "Please find enclosed herewith Outcome of the meeting of the Capital Raising Committee for Qualified institutions placement of equity shares of face value of ? 5 each (the 'Equity Shares') to qualified institutional buyers ('QIB') by Wockhardt Limited under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and Sections 42 and 62 (1) (c) of the Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of Securities) Rules, 2014, each as amended, (the 'Issue').",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6263d087-336c-4de6-aca3-fb8c45c816b3.pdf",
            "news_date": "2024-11-06 23:43:22"
        },
        {
            "co_code": 8021,
            "bse_code": 532300,
            "isin": "INE049B01025",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended, we would like to inform you that the representatives of our Company will be participating in a meeting with analysts/Institutional Investors as stated in the enclosed letter.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9838915-9560-4725-a175-89bec07f4a00.pdf",
            "news_date": "2024-10-25 20:03:10"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Investor Presentation.",
            "news_id": "253c16bc-347e-4459-be68-98085cdbc70b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4621e1ef-09ad-4f6c-aff3-b3eff866e4e1.pdf",
            "news_date": "2024-10-21 09:00:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today ie; 9th August, 2024 have approved Unaudited Financial Results for the quarter ended 30th June, 2024 along with the Limited Review Report.",
            "news_id": "90a2ce0b-b65f-42ec-ad52-1f2397ad891c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3cf4371-c2eb-4aef-aa66-fe01c309da8a.pdf",
            "news_date": "2024-08-09 15:19:27",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On May 28, 2024",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May, 28, 2024 have approved the matters as attached in the PDF.",
            "news_id": "5cc88b6f-4500-4f70-8b28-3630eb752573",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12bd8d99-7b9e-4c6f-9abb-47f54b181090.pdf",
            "news_date": "2024-05-28 19:38:15",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find herewith a copy of Investor Presentation.",
            "news_id": "ddaf9273-339d-4d4c-84bd-f03b934a9ded",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3413422b-6fcb-4520-88bf-8a86a7fc9de3.pdf",
            "news_date": "2024-02-26 12:21:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Pursuant to Regulation 30 and 33 of the Listing Regulations read with Schedule III of the Listing Regulations, we enclose herewith Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon issued by B S R & Co. LLP Statutory Auditors of the Company as approved in the Board Meeting held on 14.11.2023.",
            "news_id": "92aae4a5-0d59-451e-be85-c9e3ea997c83",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4987095b-c663-487d-a32d-96b3b3a1d57f.pdf",
            "news_date": "2023-11-14 17:50:45",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated 4th August, 2023, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 14th August, 2023, have approved the unaudited financial results (standalone & consolidated) for the quarter ended 30th June, 2023.",
            "news_id": "5f8c037d-5405-4039-a109-798a78f1b1bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de970dc9-ad87-44ca-91de-abd1a6667984.pdf",
            "news_date": "2023-08-14 14:25:56",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2023-24/034 dated 4th August, 2023, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 14th August, 2023, inter-alia to approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2023 and noted the resignation of Mr. Debashis Dey as Company Secretary of the Company with effect from end of working hours on 18th August 2023 and approved the appointment of Ms. Rashmi Mamtura in his place with effect from 19th August 2023.",
            "news_id": "2a53a213-e482-4dd9-9659-901e22d51763",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81fac08c-a3fb-4216-b9c2-efd277ff734f.pdf",
            "news_date": "2023-08-14 14:11:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); audited Financial Results of the Company as on March 31, 2023 are enclosed.",
            "news_id": "1da6220d-e388-4dc4-bfe0-ac4d5349fcb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9f12cef-7fb2-4426-a13b-94c470c321af.pdf",
            "news_date": "2023-05-26 17:25:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); outcome of the Board meeting held today i.e. 26th May, 2023 is enclosed.",
            "news_id": "4a8d06f7-00b6-4bc1-9321-0fa6801d1304",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56955f29-5596-4be0-8a97-953434e1c85e.pdf",
            "news_date": "2023-05-26 17:21:53",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and further to our communication dated February 21, 2023, please find enclosed transcript of the investor call.",
            "news_id": "a936cf1e-636c-458a-937d-f3b30ece51df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e98d36a0-d558-468c-af67-b444a5f94842.pdf",
            "news_date": "2023-02-24 15:58:08",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and further to our communication dated February 14, 2023, we enclose herewith the Investor Presentation discussed during Investor Call held today i.e. Tuesday, February 21, 2023 at 16:00 hrs IST through VC. The Investor Presentation is also available on the website of the Company at the link:https://statutory.wockhardt.com/stock_exchange_disclosures.htmDr. Habil Khorakiwala (Chairman) and Dr. Murtaza Khorakiwala (Managing Director) participated in the Investor Call. The audio - video recording of the Investor Call has been uploaded on the Company's website and the same can be accessed at the link:https://statutory.wockhardt.com/stock_exchange_disclosures.htm",
            "news_id": "796f0bb0-f530-4cc6-a422-3b7f82caec4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505a86d4-d851-4739-b561-c9c1018cedc0.pdf",
            "news_date": "2023-02-21 19:21:52",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 13th February, 2023, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022; and Limited Review Report thereon issued by B S R & Co. LLP., Statutory Auditors of the Company; <BR> <BR> Pursuant to Regulations 30 and 33 of Listing Regulations read with Schedule III of Listing Regulations, we enclose herewith the following:<BR> <BR> a. Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended <BR> 31st December, 2022; and Limited Review Report issued by B S R & Co. LLP., Statutory Auditors of the Company (enclosed as Annexure I).<BR> b. A copy of the Press Release proposed to be issued in respect of the said Financial Results (enclosed as Annexure II).<BR>",
            "news_id": "363e84c5-6850-4814-be01-a07f1c608a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a2d231-3e23-42d1-840c-06cf4a74e001.pdf",
            "news_date": "2023-02-13 15:15:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For Half Year Ended September 30, 2022 Under Reg 23(9) Of SEBI (LODR) Regulations, 2015.",
            "news_body": "Related Party Transactions for Half year ended September 30, 2022 under Reg 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "e49f6ba0-2858-4c25-a20e-905310d11c37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcc77d13-71b6-4048-bf9f-b6a5ef01f63d.pdf",
            "news_date": "2022-11-18 21:18:35",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter no. Ref. No.: WOCK/SEC/SE/2022-23/044 dated 28th October, 2022, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 4th November, 2022, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2022; and Limited Review Report issued by B S R & Co. LLP., Statutory Auditors of the Company; <BR> <BR> <BR> <BR>",
            "news_id": "4527c3c7-88a0-49d3-869e-aca0580b7946",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f21d4cd-c20e-40dd-8f30-82c301f4ddd7.pdf",
            "news_date": "2022-11-04 14:04:41",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2022",
            "news_id": "eda61759-b82a-450c-9abc-a1607b36c3e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e510d73-ac67-4022-9bcb-e3831fc9376c.pdf",
            "news_date": "2022-08-12 16:07:43",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2022",
            "news_id": "08263068-5a94-42cc-a61d-b2a60c27ce34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a99d0d32-a79a-416c-b68e-acf8a74ce632.pdf",
            "news_date": "2022-08-12 15:59:17",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Pursuant To Regulation 23(9) Of Listing Regulations, Please Find Attached The Statement Regarding Disclosure Of Related Party Transactions In The Specified Format For The Half Year Ended 31St March, 2022 Of The Company",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find attached the Statement regarding disclosure of Related Party Transactions in the specified format for the half year ended 31st March, 2022 of the Company",
            "news_id": "66e54d97-5df3-4c34-85c6-697667fb38ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c1c1e59-c478-4aa0-8c32-af7fcb8f973c.pdf",
            "news_date": "2022-06-14 17:16:04",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31.03.2022.",
            "news_body": "Audited Financial Results For The Quarter And Year Ended 31.03.2022.",
            "news_id": "cc04be6c-fcde-442b-80a2-5f75ec02299d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2185ec44-697f-4993-8ae8-c4b2b0d03a93.pdf",
            "news_date": "2022-05-30 18:31:49",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith for your information a copy of the latest investor presentation of the Company.",
            "news_id": "69702d99-f0db-4c01-b8e7-9394f77787a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c17371e-4307-4abb-88e5-6d610dceb010.pdf",
            "news_date": "2022-03-08 15:01:57",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2021.",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31.12.2021.",
            "news_id": "41c61743-a519-41a4-8037-85950a599a89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a076850-2067-4e16-9a5a-30da299db196.pdf",
            "news_date": "2022-01-27 12:54:03",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting.",
            "news_body": "Outcome of the Board Meeting held on 27th January, 2022.",
            "news_id": "a7d1b2e7-91d3-4b5c-9296-e275254177df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e109d8fa-14da-440d-bffb-b8a35825fa95.pdf",
            "news_date": "2022-01-27 12:51:01",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2021.",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30.09.2021.",
            "news_id": "46d521a6-ce8b-4935-838a-1a029132c4a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f14dfd49-56b5-4c74-a85f-899de98f24ee.pdf",
            "news_date": "2021-11-08 13:44:49",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting held on 8th November, 2021",
            "news_id": "81477fbc-cc59-4c13-a533-43973231d6e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=991cfecf-b0a4-4fd2-822b-288dcc2a6f7a.pdf",
            "news_date": "2021-11-08 13:42:01",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2021.",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.06.2021.",
            "news_id": "97e54e47-87e0-4847-9407-238f26c6da67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef03bd64-674b-4e83-871f-e290467a1fe9.pdf",
            "news_date": "2021-07-22 12:51:10",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. 22.07.2021.",
            "news_body": "Outcome of the Board Meeting held today i.e. 22.07.2021.",
            "news_id": "5834db83-c939-4ff4-beac-6f3843e5d8ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7aa3f231-f05a-4393-b0fd-8c9f57269b60.pdf",
            "news_date": "2021-07-22 12:41:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions On A Consolidated Basis For The Half Year Ended 31St March, 2021, Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Disclosure of Related Party Transaction on a consolidated basis for the half year ended 31st March, 2021, pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "6e2f4762-e2fe-4f9a-b4c4-5deb9fca47fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b64305a5-ebd3-4251-b113-d247180c5467.pdf",
            "news_date": "2021-06-17 18:14:09",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31.03.2021.",
            "news_body": "Audited Financial Results for the quarter and year ended 31.03.2021.",
            "news_id": "91f45c29-3d62-4baa-957d-548d066c475a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d047be4a-2ebc-4f64-94c1-a8f67a730091.pdf",
            "news_date": "2021-05-27 13:55:34",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. 27.05.2021.",
            "news_body": "Outcome of the Board Meeting held today i.e. 27.05.2021.",
            "news_id": "12b3e8e6-bace-4452-998b-73d0991b112b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b357a2c-b955-477a-a613-7b5d152fe9e1.pdf",
            "news_date": "2021-05-27 13:50:20",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}